Market Overview

Teva Announces Signing of New $3B Syndicated Revolving Credit Line

Share:
Related TEVA
Benzinga's M&A Chatter for Wednesday May 27, 2015
Report: Mylan Could See Sweetened Bid From Teva Pharmaceutical
Teva to pay $1.2 bil to settle (Investor's Business Daily)

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it has entered into a new five-year, $3.0 billion unsecured revolving credit facility, which replaces its existing $2.5 billion credit facility.

Posted-In: News Financing

 

Related Articles (TEVA)

Around the Web, We're Loving...